Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Actelion Pharmaceuticals US, Inc.
Current Parent Company:
Johnson & Johnson
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $360,000,000
Year: 2018
Date: December 6, 2018
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: kickbacks and bribery
Mega-Scandal:
Healthcare Kickbacks
Violation Description: Pharmaceutical company Actelion Pharmaceuticals US, Inc. agreed to pay $360 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Actelion's pulmonary arterial hypertension drugs, in violation of the False Claims Act.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Archived Source:
(click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
